Polysaccharide-based nanocomplexes for co-encapsulation and controlled release of 5-Fluorouracil and Temozolomide
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
27154260
DOI
10.1016/j.ejps.2016.05.001
PII: S0928-0987(16)30155-5
Knihovny.cz E-zdroje
- Klíčová slova
- 5-Fluorouracil (PubChem CID: 3385), Alginic acid, Alginic acid (PubChem CID: 44630049), Chitosan, Chitosan (PubChem CID: 21896651), Drug delivery, Polyelectrolytes, Polygalacturonic acid, Polygalacturonic acid (PubChem CID: 439215), Temozolomide (PubChem CID: 11830328),
- MeSH
- algináty chemie MeSH
- alkylační protinádorové látky chemie MeSH
- chitosan chemie MeSH
- dakarbazin analogy a deriváty chemie MeSH
- fixní kombinace léků MeSH
- fluoruracil chemie MeSH
- kyselina glukuronová chemie MeSH
- kyseliny hexuronové chemie MeSH
- léky s prodlouženým účinkem chemie MeSH
- nanočástice chemie MeSH
- nosiče léků chemie MeSH
- pektiny chemie MeSH
- prekurzory léčiv chemie MeSH
- příprava léků MeSH
- protinádorové antimetabolity chemie MeSH
- stabilita léku MeSH
- temozolomid MeSH
- uvolňování léčiv MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- algináty MeSH
- alkylační protinádorové látky MeSH
- chitosan MeSH
- dakarbazin MeSH
- fixní kombinace léků MeSH
- fluoruracil MeSH
- kyselina glukuronová MeSH
- kyseliny hexuronové MeSH
- léky s prodlouženým účinkem MeSH
- nosiče léků MeSH
- pektiny MeSH
- polygalacturonic acid MeSH Prohlížeč
- prekurzory léčiv MeSH
- protinádorové antimetabolity MeSH
- temozolomid MeSH
Polysaccharide-based nanocomplexes, intended for simultaneous encapsulation and controlled release of 5-Fluorouracil (5-FU) and Temozolomide (TMZ) were developed via the complexation method using chitosan, alginic and polygalacturonic acid. Investigation focused on the influence of polysaccharides on the properties of the system and amelioration of the stability of the drugs, in particular TMZ. The dimensions of particles and their ζ-potential were found to range between 100 and 200nm and -25 to +40mV, respectively. Encapsulation efficiency varied from 16% to over 70%, depending on the given system. The influence of pH on the release and co-release of TMZ and 5-FU was evaluated under different pH conditions. The stability of the loaded drug, in particular TMZ, after release was evaluated and confirmed by LC-MS analysis. Results suggested that the amount of loaded drug(s) and the release rate is connected with the weight ratio of polysaccharides and the pH of the media. One-way ANOVA analysis on the obtained data revealed no interference between the drugs during the encapsulation and release process, and in particular no hydrolysis of TMZ occurred suggesting that CS-ALG and CS-PGA would represent interesting carriers for multi-drug controlled release and drugs protection.
Citace poskytuje Crossref.org